Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$183,667
+$72,101 QoQ
Shares Held
4,695
+13.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 155 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,724 across 427 Biotechnology names. RIGL ranks #111 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in RIGL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,667 | 4,695 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $111,566 | 4,126 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $202,670 | 4,732 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $175,843 | 6,207 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $193,198 | 10,315 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $248,657 | 13,822 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $301,229 | 17,909 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $27,909 | 1,725 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,165 | 5,738 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $6,030 | 4,075 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $79,639 | 54,925 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,157 | 26,998 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,870 | 16,179 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $104,499 | 79,167 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $366,055 | 244,037 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $110,524 | 93,665 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,679 | 5,026 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $46,339 | 15,498 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $112,423 | 42,424 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $81,794 | 22,533 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $70,299 | 16,198 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $60,742 | 17,761 | Shares | Defined | 2021-07-20 | |
| 2020-09-30 | $2,232 | 930 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $23,667 | 12,933 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $45,780 | 29,347 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||